Epileptogenic activity of methicillin-resistant Staphylococcus aureus (MRSA) antibiotics in rats

Biological and Pharmaceutical Bulletin

Volumn 29, Issue 10, 2006, Pages 2035-2040

  Rahman, Md Ashequr ^a   Jun, Ago ^a   Matsumoto, Naotaka ^a   Ishikawa, Takashi ^a   Kamei, Chiaki ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Electroencephalographic (EEG); Epileptogenic activity; Intracerebroventricular injection (i.c.v.); Methicillin resistance Staphylococcus aureus (MRSA); Teicoplanin; Vancomycin

Indexed keywords

ANTIBIOTIC AGENT; CEFAZOLIN; FOSFOMYCIN; FOSMICIN S; PENICILLIN G; TEICOPLANIN; VANCOMYCIN;

ANIMAL EXPERIMENT; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DRUG ACTIVITY; ELECTROENCEPHALOGRAPHY; FEMALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; RAT; SEIZURE;

ANIMALS; ANTI-BACTERIAL AGENTS; ELECTROENCEPHALOGRAPHY; EPILEPSY; MALE; METHICILLIN RESISTANCE; RATS; RATS, WISTAR; STAPHYLOCOCCUS AUREUS; TEICOPLANIN; VANCOMYCIN;

EID: 33749445777     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.29.2035     Document Type: Article

References (19)

1. Banning M., Br. J. Nurs., 14, 548-551 (2005).
2. Zetola N., Francis J. S., Nuermberger E. L., Bishai W., Lancet Infect. Dis., 5, 275-286 (2005).
3. Crum N. F., Scand. J. Infect. Dis., 37, 651-656 (2005).
4. Arda B., Yamazhan T., Sipahi O. R., Islekel Sertac Buke C., Ulusoy S., Int. J. Antimicrob. Agents, 25, 414-418 (2005).
5. Nakazawa H., Kikuchi Y., Honda T., Isago T., Nozaki M., J. Infect. Chemother., 9, 304-309 (2003).
6. Boger D. L., Med. Res. Rev., 21, 356-381 (2001).
7. Losonsky G. A., Wolf A., Schwalbe R. S., Nataro J., Gibson C. B., Lewis E. W., Clin. Infect. Dis., 19, 163-165 (1994).
8. Kamei C., Sunami A., Tasaka K., Epilepsia, 24, 431-439 (1983).
9. Yu Q. H., Kitazumi K., Kamei C., Tasaka K., J. Pharmacobio-Dyn., 7, 586-592 (1984).
10. Krieg W. J. S., Q. Bull. Northwest Univ. Med. School, 20, 199-208 (1946).
11. de Groot J., Trans. R. Neth. Acad. Sci., 52, 1-40 (1959).
12. Grondahl T. O., Langmoen I. A., J. Neurosurg., 78, 938-943 (1993).
13. Moellering R. C., J. Antimicrob. Chemother., 14, 43-52 (1984).
14. Bambeke F. V., Current Opinion Pharmacol., 4, 471-478 (2004).
15. Marangoz C., Bagirici F., Jpn. J. Pharmacol., 86, 297-301 (2001).
16. Van Gelder N. M., Siatitsas I. C., Menini C., Gloor P., Epilepsia, 24, 200-213 (1983).
17. De Sarro G. B., Nistico G., Meldrum B. S., Neuropharmacol., 25, 695-701 (1986).
18. Morocutti C., Pierelli F., Sanarelli L., Stefano E., Peppe A., Mattioli G. L., Epilepsia, 27, 498-503 (1986).
19. Walden J., Speckmann E. J., Witte O. W., Electroencephalogr. Clin. Neurophysiol., 61, 299-309 (1985).